These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23790539)

  • 21. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
    Xu S; An B; Li Y; Luo X; Li X; Jia X
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
    Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
    Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
    Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
    J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformationally restricted analogs of Combretastatin A-4 derived from SU5416.
    Li PK; Xiao Z; Hu Z; Pandit B; Sun Y; Sackett DL; Werbovetz K; Lewis A; Johnsamuel J
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5382-5. PubMed ID: 16213720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of a terphenyl substituted 4-aza-2,3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerization and apoptosis inducers.
    Kamal A; Tamboli JR; Nayak VL; Adil SF; Vishnuvardhan MV; Ramakrishna S
    Bioorg Med Chem; 2014 May; 22(9):2714-23. PubMed ID: 24721832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
    Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
    Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors.
    Kamal A; Srinivasa Reddy T; Polepalli S; Paidakula S; Srinivasulu V; Ganga Reddy V; Jain N; Shankaraiah N
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3356-60. PubMed ID: 24953821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors.
    Shobeiri N; Rashedi M; Mosaffa F; Zarghi A; Ghandadi M; Ghasemi A; Ghodsi R
    Eur J Med Chem; 2016 May; 114():14-23. PubMed ID: 26974371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Combretastatin A-4 Analogs-Design, Synthesis, and Antiproliferative and Anti-Tubulin Activity.
    Jędrzejczyk M; Morabito B; Żyżyńska-Granica B; Struga M; Janczak J; Aminpour M; Tuszynski JA; Huczyński A
    Molecules; 2024 May; 29(10):. PubMed ID: 38792062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.
    Prakasham AP; Saxena AK; Luqman S; Chanda D; Kaur T; Gupta A; Yadav DK; Chanotiya CS; Shanker K; Khan F; Negi AS
    Bioorg Med Chem; 2012 May; 20(9):3049-57. PubMed ID: 22472045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
    Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
    Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
    Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
    Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.
    La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R
    Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel cyanocombretastatins as potent tubulin polymerisation inhibitors.
    Jalily PH; Hadfield JA; Hirst N; Rossington SB
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6731-4. PubMed ID: 23010271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents.
    Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC
    J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
    Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
    Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold.
    Xu Q; Sun M; Bai Z; Wang Y; Wu Y; Tian H; Zuo D; Guan Q; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2017 Oct; 139():242-249. PubMed ID: 28802124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
    Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
    Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.